Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.07.2023 | Case report

Flecainide

Polymorphic ventricular tachycardia and worsening of Brugada syndrome following flecainide toxicity: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Salvarani N, et al. Functional Characterisation of the Rare SCN5A p.E1225K Variant, Segregating in a Brugada Syndrome Familial Case, in Human Cardiomyocytes from Pluripotent Stem Cells. International Journal of Molecular Sciences 24: 1-13, No. 11, 31 May 2023. Available from: URL: https://www.mdpi.com/1422-0067/24/11/9548 Salvarani N, et al. Functional Characterisation of the Rare SCN5A p.E1225K Variant, Segregating in a Brugada Syndrome Familial Case, in Human Cardiomyocytes from Pluripotent Stem Cells. International Journal of Molecular Sciences 24: 1-13, No. 11, 31 May 2023. Available from: URL: https://​www.​mdpi.​com/​1422-0067/​24/​11/​9548
Metadaten
Titel
Flecainide
Polymorphic ventricular tachycardia and worsening of Brugada syndrome following flecainide toxicity: case report
Publikationsdatum
01.07.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-42754-x

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Multiple drugs

Case report

Catequentinib

Case report

Ceftriaxone

Case report

Osimertinib